Progesterone Management in Clinical Scenarios
Introduction to Progesterone Measurement and Supplementation
- Progesterone levels <1 ng/mL on cycle day 3 are physiologically normal and expected, as day 3 falls within the follicular phase when progesterone should be low, according to the American Academy of Neurology 1
- Mid-luteal progesterone <6 nmol/L (approximately <2 ng/mL) indicates anovulation and requires intervention, as stated by the American College of Obstetricians and Gynecologists 1
Clinical Scenarios Requiring Progesterone Supplementation
- For women with PCOS who are not attempting conception and have anovulatory cycles, medroxyprogesterone acetate (MPA) 10 mg daily for 12-14 days per month is the first-line recommendation to induce withdrawal bleeding and provide endometrial protection, as recommended by the American College of Obstetricians and Gynecologists 2
- Alternative options for endometrial protection include oral micronized progesterone (OMP) 200 mg daily for 12-14 days per month, dydrogesterone 10 mg daily for 12-14 days per month, and vaginal progesterone 200 mg daily for 12-14 days per month, according to the Endocrine Society 2
- MPA is the only progestin with robust evidence demonstrating full effectiveness in inducing secretory endometrium when used cyclically, as stated by the American College of Obstetricians and Gynecologists 2
Algorithm for Management
- Confirm timing of progesterone measurement - if measured on day 3, repeat during mid-luteal phase, as recommended by the American Academy of Neurology 1
- If mid-luteal progesterone <6 nmol/L (anovulation confirmed), not seeking pregnancy, MPA 10 mg daily for 12-14 days/month is recommended, according to the American College of Obstetricians and Gynecologists 2